Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2017-01-11

Clinical Trial Update: Fecal Microbiota Transplantation for Ulcerative Colitis [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial update indicates Phase 1 and Phase 2 studies are ongoing to evaluate fecal microbiota transplantation as a treatment for ulcerative colitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fecal microbiota transplantation (fecal microbiota transplantation)

Snippet

Sponsor: First Affiliated Hospital of Chengdu Medical College | Conditions: Ulcerative Colitis, Intestinal Bacteria Flora Disturbance | Phase 1, Phase 2 | Status: UNKNOWN